Cargando…

Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy

OBJECTIVE: Diabetic nephropathy is associated with dedifferentiation of podocytes, losing the specialized features required for efficient glomerular function and acquiring a number of profibrotic, proinflammatory, and proliferative features. These result from tight junction and cytoskeletal rearrang...

Descripción completa

Detalles Bibliográficos
Autores principales: Herman-Edelstein, Michal, Thomas, Merlin C., Thallas-Bonke, Vicki, Saleem, Moin, Cooper, Mark E., Kantharidis, Phillip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114395/
https://www.ncbi.nlm.nih.gov/pubmed/21521871
http://dx.doi.org/10.2337/db10-1110
_version_ 1782206060903268352
author Herman-Edelstein, Michal
Thomas, Merlin C.
Thallas-Bonke, Vicki
Saleem, Moin
Cooper, Mark E.
Kantharidis, Phillip
author_facet Herman-Edelstein, Michal
Thomas, Merlin C.
Thallas-Bonke, Vicki
Saleem, Moin
Cooper, Mark E.
Kantharidis, Phillip
author_sort Herman-Edelstein, Michal
collection PubMed
description OBJECTIVE: Diabetic nephropathy is associated with dedifferentiation of podocytes, losing the specialized features required for efficient glomerular function and acquiring a number of profibrotic, proinflammatory, and proliferative features. These result from tight junction and cytoskeletal rearrangement, augmented proliferation, and apoptosis. RESEARCH DESIGN AND METHODS: Experiments were performed in conditionally immortalized human podocytes developed by transfection with the temperature-sensitive SV40-T gene. Cells were then cultured in the presence of transforming growth factor (TGF)-β1 or angiotensin II in the presence or absence of a selective inhibitor of the TGF-β type I receptor kinase, SB-431542. Gene and protein expression were then examined by real-time RT-PCR and immunofluorescence, and correlated with changes observed in vivo in experimental diabetes. RESULTS: Treatment of cells with TGF-β1 resulted in dynamic changes in their morphology, starting with retraction and shortening of foot processes and finishing with the formation of broad and complex tight junctions between adjacent podocytes. This dedifferentiation was also associated with dose- and time-dependent reduction in the expression of glomerular epithelial markers (nephrin, p-cadherin, zonnula occludens-1) and increased expression of mesenchymal markers (α−smooth muscle actin, vimentin, nestin), matrix components (fibronectin, collagen I, and collagen IV α3), cellular proliferation, and apoptosis. The induction of diabetes in mice was also associated with similar changes in morphology, protein expression, and proliferation in glomerular podocytes. CONCLUSIONS: In response to TGF-β and other TGF-dependent stimuli, mature podocytes undergo dedifferentiation that leads to effacement of foot processes, morphologic flattening, and increased formation of intercellular tight junctions. This simplification of their phenotype to a more embryonic form is also associated with reentry of mature podocytes into the cell cycle, which results in enhanced proliferation and apoptosis. These “pathoadaptive” changes are seen early in the diabetic glomerulus and ultimately contribute to albuminuria, glomerulosclerosis, and podocytopenia.
format Online
Article
Text
id pubmed-3114395
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-31143952012-06-01 Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy Herman-Edelstein, Michal Thomas, Merlin C. Thallas-Bonke, Vicki Saleem, Moin Cooper, Mark E. Kantharidis, Phillip Diabetes Complications OBJECTIVE: Diabetic nephropathy is associated with dedifferentiation of podocytes, losing the specialized features required for efficient glomerular function and acquiring a number of profibrotic, proinflammatory, and proliferative features. These result from tight junction and cytoskeletal rearrangement, augmented proliferation, and apoptosis. RESEARCH DESIGN AND METHODS: Experiments were performed in conditionally immortalized human podocytes developed by transfection with the temperature-sensitive SV40-T gene. Cells were then cultured in the presence of transforming growth factor (TGF)-β1 or angiotensin II in the presence or absence of a selective inhibitor of the TGF-β type I receptor kinase, SB-431542. Gene and protein expression were then examined by real-time RT-PCR and immunofluorescence, and correlated with changes observed in vivo in experimental diabetes. RESULTS: Treatment of cells with TGF-β1 resulted in dynamic changes in their morphology, starting with retraction and shortening of foot processes and finishing with the formation of broad and complex tight junctions between adjacent podocytes. This dedifferentiation was also associated with dose- and time-dependent reduction in the expression of glomerular epithelial markers (nephrin, p-cadherin, zonnula occludens-1) and increased expression of mesenchymal markers (α−smooth muscle actin, vimentin, nestin), matrix components (fibronectin, collagen I, and collagen IV α3), cellular proliferation, and apoptosis. The induction of diabetes in mice was also associated with similar changes in morphology, protein expression, and proliferation in glomerular podocytes. CONCLUSIONS: In response to TGF-β and other TGF-dependent stimuli, mature podocytes undergo dedifferentiation that leads to effacement of foot processes, morphologic flattening, and increased formation of intercellular tight junctions. This simplification of their phenotype to a more embryonic form is also associated with reentry of mature podocytes into the cell cycle, which results in enhanced proliferation and apoptosis. These “pathoadaptive” changes are seen early in the diabetic glomerulus and ultimately contribute to albuminuria, glomerulosclerosis, and podocytopenia. American Diabetes Association 2011-06 2011-05-21 /pmc/articles/PMC3114395/ /pubmed/21521871 http://dx.doi.org/10.2337/db10-1110 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Complications
Herman-Edelstein, Michal
Thomas, Merlin C.
Thallas-Bonke, Vicki
Saleem, Moin
Cooper, Mark E.
Kantharidis, Phillip
Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy
title Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy
title_full Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy
title_fullStr Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy
title_full_unstemmed Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy
title_short Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β: A Model for Diabetic Podocytopathy
title_sort dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathy
topic Complications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114395/
https://www.ncbi.nlm.nih.gov/pubmed/21521871
http://dx.doi.org/10.2337/db10-1110
work_keys_str_mv AT hermanedelsteinmichal dedifferentiationofimmortalizedhumanpodocytesinresponsetotransforminggrowthfactorbamodelfordiabeticpodocytopathy
AT thomasmerlinc dedifferentiationofimmortalizedhumanpodocytesinresponsetotransforminggrowthfactorbamodelfordiabeticpodocytopathy
AT thallasbonkevicki dedifferentiationofimmortalizedhumanpodocytesinresponsetotransforminggrowthfactorbamodelfordiabeticpodocytopathy
AT saleemmoin dedifferentiationofimmortalizedhumanpodocytesinresponsetotransforminggrowthfactorbamodelfordiabeticpodocytopathy
AT coopermarke dedifferentiationofimmortalizedhumanpodocytesinresponsetotransforminggrowthfactorbamodelfordiabeticpodocytopathy
AT kantharidisphillip dedifferentiationofimmortalizedhumanpodocytesinresponsetotransforminggrowthfactorbamodelfordiabeticpodocytopathy